Market Place
Sourcing Support
Charles River Lab to Present at UBS & Jefferies Conferences
11 Nov 2024 //
BUSINESSWIRE
Charles River Laboratories Announces Third-Quarter 2024 Results
06 Nov 2024 //
BUSINESSWIRE
NJ Bio & Charles River Form ADC Development Alliance
05 Nov 2024 //
BUSINESSWIRE
Charles River Launches New Retrogenix® Non-Human Protein Library
17 Oct 2024 //
BUSINESSWIRE
Charles River Provides Translational Expertise at Neuroscience 2024
03 Oct 2024 //
BUSINESSWIRE
Lundbeck taps Charles River for AI-enabled neuro drug discovery
02 Oct 2024 //
FIERCE BIOTECH
Ori Biotech And Charles River Partner For Cell Therapies
18 Sep 2024 //
GLOBENEWSWIRE
Ori Enhances Charles River Collaboration With Cell Therapy Platform Data
18 Sep 2024 //
FIERCE PHARMA
Charles River And CEBINA Collaborate To Accelerate Neuroscience Research
17 Sep 2024 //
BUSINESSWIRE
Charles River and Insightec Collaborate on Focused Ultrasound in Neuroscience
04 Sep 2024 //
BUSINESSWIRE
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
03 Sep 2024 //
BUSINESSWIRE
Charles River Laboratories Announces Second-Quarter 2024 Results
07 Aug 2024 //
BUSINESSWIRE
Charles River And Gates Institute Collaborate On Lentiviral Vector Production
25 Jun 2024 //
PRESS RELEASE
Charles collaborates with Gates University for lentiviral vector manufacturing.
25 Jun 2024 //
BUSINESSWIRE
Charles River And Captain T Cell Partner On Cell Therapy Manufacturing
17 Jun 2024 //
PRESS RELEASE
Charles River And Captain T Cell Form Alliance For Gene-Modified Cell Therapy
17 Jun 2024 //
BUSINESSWIRE
Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Deal
17 Jun 2024 //
CONTRACT PHARMA
Charles River Expands CRADL® Vivarium Access In Somerville
06 Jun 2024 //
BUSINESSWIRE
Charles River: Nonclinical Virtual Controls With Sanofi Reduce Animal Use
04 Jun 2024 //
BUSINESSWIRE
Charles River Laboratories to Present at William Blair and Jefferies Conferences
03 Jun 2024 //
BUSINESSWIRE
Charles River Launches Viral Vector Tech Transfer For Gene Therapy Safety
30 May 2024 //
PRESS RELEASE
Charles River Safeguards Gene Therapy With Viral Vector Program
30 May 2024 //
BUSINESSWIRE
Titian: Charles River Commits To Mosaic Sample Management Software
28 May 2024 //
BUSINESSWIRE
Charles River Laboratories Announces First-Quarter 2024 Results
09 May 2024 //
BUSINESSWIRE
Charles River touts 1Q manufacturing revenue, says China bill is ‘net positive’
09 May 2024 //
ENDPTS
Charles River Lab Launches Viral Vector Reference Materials to Streamline
02 May 2024 //
PRESS RELEASE
Charles River Launches Viral Vector Reference Materials
02 May 2024 //
BUSINESSWIRE
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
22 Apr 2024 //
BUSINESSWIRE
Charles River Lab Schedules 1Q 2024 Earnings Release and Conference Call
12 Apr 2024 //
PRESS RELEASE
Charles River Q1 2024 Earnings Release, Call Scheduled
12 Apr 2024 //
BUSINESSWIRE
Charles River, Deciphex Launch AI Patholytix Foresight Tool
11 Apr 2024 //
BUSINESSWIRE
Charles River & Axovia Partner to Support Gene Therapies for Ciliopathies
09 Apr 2024 //
CONTRACTPHARMA
Charles River to Perform Plasmid Production for Ship of Theseus
04 Apr 2024 //
BUSINESSWIRE
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
01 Apr 2024 //
BUSINESSWIRE
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
27 Mar 2024 //
BUSINESSWIRE
Charles River And Navega Partner On Gene Therapy Manufacturing
14 Mar 2024 //
PRESS RELEASE
Charles River and Navega Announce Gene Therapy Manufacturing Collaboration
14 Mar 2024 //
BUSINESSWIRE
DURECT and Charles River Enter into Collaboration Agreement for ALZET
04 Mar 2024 //
PR NEWSWIRE
Wheeler Bio Seals Agreement with Charles River
29 Feb 2024 //
PR NEWSWIRE
Charles River Lab & Wheeler Bio Complete Agreement to Accelerate the CMC
21 Feb 2024 //
PRESS RELEASE
Charles River and Wheeler Bio Complete Agreement
21 Feb 2024 //
BUSINESSWIRE
Charles River LabCollaborates with Pluristyx, Expanding its Portfolio
20 Feb 2024 //
PRESS RELEASE
Charles River Collaborates with Pluristyx
20 Feb 2024 //
BUSINESSWIRE
Charles River Laboratories Announces Fourth Quarter and Full-Year 2023
14 Feb 2024 //
PRESS RELEASE
Charles River Announces Fourth Quarter and Full-Year 2023 Results
14 Feb 2024 //
BUSINESSWIRE
Charles River forecasts strong full-year profit on boost from Noveprim purchase
14 Feb 2024 //
REUTERS
Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
29 Jan 2024 //
BUSINESSWIRE
Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
24 Jan 2024 //
BUSINESSWIRE
Charles River Lab Schedules Fourth-Quarter 2023 Earnings and 2024
23 Jan 2024 //
PRESS RELEASE
Charles River Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release
23 Jan 2024 //
BUSINESSWIRE
Charles River Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector
16 Jan 2024 //
PRESS RELEASE
Charles River Launches Rep/Cap Plasmids to Streamline Vector Manufacturing
16 Jan 2024 //
BUSINESSWIRE
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
08 Jan 2024 //
BUSINESSWIRE
Charles River to make Casgevy; Rentschler extends collab with ‘major client
21 Dec 2023 //
ENDPTS
Charles River hits milestone on quest to manufacture Casgevy
18 Dec 2023 //
FIERCE PHARMA
Charles River Finalizes Agreement with CELLphenomics
12 Dec 2023 //
BUSINESSWIRE
Charles River and Genetic Cures Announce Gene Therapy Collaboration
28 Nov 2023 //
BUSINESSWIRE
Charles River Laboratories to Present at Evercore ISI Investor Conference
27 Nov 2023 //
BUSINESSWIRE
Charles River Introduces CliniPrime Cryopreserved Leukopaks
16 Nov 2023 //
BUSINESSWIRE
Charles River and Aitia Enter Strategic Agreement to Utilize Logica
13 Nov 2023 //
BUSINESSWIRE
